← Back to All Filings

Incyte Officer Files Intent to Sell $18.2M in Company Stock

Low SignificanceDecember 15, 2025 at 5:33:00 PM EST

INCYTE CORP

$INCY144CIK: 0000879169

Subscribe to track INCY

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Incyte Officer Files Intent to Sell $18.2M in Company Stock

Company: INCYTE CORPORATION (INCY) Form: 144 | Filed: 2025-12-15 Significance: Low

Insider: CHRISTIANA STAMOULIS Title: Officer | Relationship: Officer

Transaction: • Type: Proposed Sale • Shares: 187,690 • Price: ~$97.00 • Value: $18,205,930 • Owned After: Not Disclosed

Key Insight: An officer has filed a notice of proposed sale for shares acquired via stock option exercise. While the dollar amount is substantial, it represents less than 0.1% of the company's market capitalization, indicating a routine transaction.

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: INCYTE CORPORATION (INCY)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An officer at Incyte filed a Form 144, signaling their intent to sell $18.2 million worth of common stock, acquired through a stock option exercise.
  • Market Impact: The transaction is not considered material, representing less than 0.1% of Incyte's total market capitalization and shares outstanding.

Company Information

FieldValue
CompanyINCYTE CORPORATION
Ticker SymbolINCY
CIK0000879169
IndustryCommercial Physical & Biological Research

Insider Information

FieldValue
NameCHRISTIANA STAMOULIS
CIK0001502917
Title/PositionOfficer
RelationshipOfficer

Transaction Details

FieldValue
Form Type144
Transaction Date2025-12-15
Transaction CodeNot Applicable (Proposed Sale)
Security TypeCommon Stock
Shares Involved187,690
Price Per Share$97.00
Total Value$18,205,930
Shares Owned AfterNot Disclosed
Ownership TypeNot Disclosed

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$18,205,930
% of Market Cap0.089%
Shares Transacted187,690
% of Shares Outstanding0.096%
Post-Transaction OwnershipNot Disclosed
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a large-cap company with a market capitalization of $20.45 billion, this $18.2 million transaction is minor and unlikely to influence the market's perception of the stock.
  • Ownership Concentration: Post-transaction ownership is not disclosed, but the sale size relative to total shares outstanding is minimal.
  • Transaction Significance: The sale represents a very small fraction of the company's value (0.089% of market cap) and public float (0.096% of shares outstanding). Such transactions are common for executives managing personal finances and exercising compensation-related options.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is a notice of a proposed sale and is not material relative to the company's size. It is likely part of a pre-planned financial strategy or compensation exercise rather than a signal of a change in the insider's outlook on the company.

Volume & Sentiment

  • Expected Volume Impact: Minimal. The number of shares is small compared to the stock's typical daily trading volume.
  • Sentiment Indicator: Neutral. The market generally does not react to low-significance insider sales, especially those linked to option exercises.

Additional Context

Transaction Notes

  • Source of Shares: The filing indicates the shares to be sold were acquired on the same day through a 'Stock Option Exercise', a common cashless transaction for executives.
  • Prior Sales: The filing also notes several smaller sales by the same insider in the preceding three months, suggesting a pattern of periodic selling.
Topics:#SECFiling#InsiderTrading#INCY#Incyte#Form144#InsiderSell#StockMarket#Investing#Biotech

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.